BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 27998976)

  • 1. Sialylation Controls Prion Fate
    Srivastava S; Katorcha E; Daus ML; Lasch P; Beekes M; Baskakov IV
    J Biol Chem; 2017 Feb; 292(6):2359-2368. PubMed ID: 27998976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sialylation of prion protein controls the rate of prion amplification, the cross-species barrier, the ratio of PrPSc glycoform and prion infectivity.
    Katorcha E; Makarava N; Savtchenko R; D'Azzo A; Baskakov IV
    PLoS Pathog; 2014 Sep; 10(9):e1004366. PubMed ID: 25211026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversible off and on switching of prion infectivity via removing and reinstalling prion sialylation.
    Katorcha E; Daus ML; Gonzalez-Montalban N; Makarava N; Lasch P; Beekes M; Baskakov IV
    Sci Rep; 2016 Sep; 6():33119. PubMed ID: 27609323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sialylation of the prion protein glycans controls prion replication rate and glycoform ratio.
    Katorcha E; Makarava N; Savtchenko R; Baskakov IV
    Sci Rep; 2015 Nov; 5():16912. PubMed ID: 26576925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of sialylation in prion disease pathogenesis and prion structure.
    Baskakov IV
    Prog Mol Biol Transl Sci; 2020; 175():31-52. PubMed ID: 32958238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sialylation of Glycosylphosphatidylinositol (GPI) Anchors of Mammalian Prions Is Regulated in a Host-, Tissue-, and Cell-specific Manner.
    Katorcha E; Srivastava S; Klimova N; Baskakov IV
    J Biol Chem; 2016 Aug; 291(33):17009-19. PubMed ID: 27317661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of sialylation of N-linked glycans in prion pathogenesis.
    Makarava N; Baskakov IV
    Cell Tissue Res; 2023 Apr; 392(1):201-214. PubMed ID: 35088180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Region-Specific Sialylation Pattern of Prion Strains Provides Novel Insight into Prion Neurotropism.
    Makarava N; Chang JC; Baskakov IV
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32012886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-conversion sialylation of prions in lymphoid tissues.
    Srivastava S; Makarava N; Katorcha E; Savtchenko R; Brossmer R; Baskakov IV
    Proc Natl Acad Sci U S A; 2015 Dec; 112(48):E6654-62. PubMed ID: 26627256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highly efficient protein misfolding cyclic amplification.
    Gonzalez-Montalban N; Makarava N; Ostapchenko VG; Savtchenk R; Alexeeva I; Rohwer RG; Baskakov IV
    PLoS Pathog; 2011 Feb; 7(2):e1001277. PubMed ID: 21347353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analyses of N-linked glycans of PrP
    Katorcha E; Baskakov IV
    FEBS J; 2017 Nov; 284(21):3727-3738. PubMed ID: 28898525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of Covalent Modifications of Amyloidogenic Proteins Using Two-Dimensional Electrophoresis: Prion Protein and Its Sialylation.
    Katorcha E; Baskakov IV
    Methods Mol Biol; 2018; 1779():241-255. PubMed ID: 29886537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sc237 hamster PrPSc and Sc237-derived mouse PrPSc generated by interspecies in vitro amplification exhibit distinct pathological and biochemical properties in tga20 transgenic mice.
    Yoshioka M; Imamura M; Okada H; Shimozaki N; Murayama Y; Yokoyama T; Mohri S
    Microbiol Immunol; 2011 May; 55(5):331-40. PubMed ID: 21362027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of strain-specific PrP(Sc) elongation rates revealed a transformation of PrP(Sc) properties during protein misfolding cyclic amplification.
    Gonzalez-Montalban N; Baskakov IV
    PLoS One; 2012; 7(7):e41210. PubMed ID: 22815972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multifaceted Role of Sialylation in Prion Diseases.
    Baskakov IV; Katorcha E
    Front Neurosci; 2016; 10():358. PubMed ID: 27551257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of genuine prion infectivity by serial PMCA.
    Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
    Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autocatalytic self-propagation of misfolded prion protein.
    Bieschke J; Weber P; Sarafoff N; Beekes M; Giese A; Kretzschmar H
    Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12207-11. PubMed ID: 15297610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective amplification of classical and atypical prions using modified protein misfolding cyclic amplification.
    Makarava N; Savtchenko R; Baskakov IV
    J Biol Chem; 2013 Jan; 288(1):33-41. PubMed ID: 23168413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new mechanism for transmissible prion diseases.
    Makarava N; Kovacs GG; Savtchenko R; Alexeeva I; Ostapchenko VG; Budka H; Rohwer RG; Baskakov IV
    J Neurosci; 2012 May; 32(21):7345-55. PubMed ID: 22623680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limited understanding of the functional diversity of N-linked glycans as a major gap of prion biology.
    Baskakov IV
    Prion; 2017 Mar; 11(2):82-88. PubMed ID: 28324664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.